期刊
ADVANCED HEALTHCARE MATERIALS
卷 7, 期 3, 页码 -出版社
WILEY
DOI: 10.1002/adhm.201700701
关键词
circulating tumor cells; poly(3, 4-ethylene-dioxythiophene)s; prostate cancer; responsive materials; RNA biomarkers
资金
- Ministry of Science and Technology (MOST) of Taiwan [MOST-104-2113-M-001-025-MY2]
- Academia Sinica Research Project on Nano Science and Technology
- Academia Sinica Thematic Project
- DoD [W81XWH-11-1-0422, PC151088]
- Steven Spielberg Discovery Fund in Prostate Cancer Research
- Prostate Cancer Foundation (PCF)
- St. Anthony Prostate Cancer Research Fund
- CD McKinnon Memorial Fund for Neuroendocrine Prostate Cancer
- Berns Family Fund
- PCF
- UCLA Prostate Cancer SPORE Program
- NIH/NCI Innovative Molecular Analysis Technologies (IMAT) Program [R21 CA151159, R33 CA157396]
- NIH/NCI Alliance for Nanotechnology in Cancer program [U01 CA 198900]
- NATIONAL CANCER INSTITUTE [R01CA218356, R33CA157396, R21CA151159, U01CA198900, R33CA174562] Funding Source: NIH RePORTER
A glycan-stimulated and poly(3,4-ethylene-dioxythiophene)s (PEDOT)-based nanomaterial platform is fabricated to purify circulating tumor cells (CTCs) from blood samples of prostate cancer (PCa) patients. This new platform, phenylboronic acid (PBA)-grafted PEDOT NanoVelcro, combines the 3D PEDOT nanosubstrate, which greatly enhances CTC capturing efficiency, with a poly(EDOT-PBA-co-EDOT-EG3) interfacial layer, which not only provides high specificity for CTC capture upon antibody conjugation but also enables competitive binding of sorbitol to gently release the captured cells. CTCs purified by this PEDOT NanoVelcro chip provide well-preserved RNA transcripts for the analysis of the expression level of several PCa-specific RNA biomarkers, which may provide clinical insights into the disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据